Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Original Article

A.D. Pradhan, R.J. Glynn, J.-C. Fruchart, J.G. MacFadyen, E.S. Zaharris, B.M. Everett, S.E. Campbell, R. Oshima, P. Amarenco, D.J. Blom, E.A. Brinton, R.H. Eckel, M.B. Elam, J.S. Felicio, H.N. Ginsberg, A. Goudev, S. Ishibashi, J. Joseph, T. Kodama, W. Koenig, L.A. Leiter, A.J. Lorenzatti, B. Mankovsky, N. Marx, B.G. Nordestgaard, D. Páll, K.K. Ray, R.D. Santos, H. Soran, A. Susekov, M. Tendera, K. Yokote, N.P. Paynter, J.E. Buring, P. Libby, and P.M. Ridker

N Engl J Med 2022;387:1923-1934

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
11/23/2022
Course expires: 
11/24/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation